Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

8 results
Display

Emergency Cervical Carotid Artery Stenting After Intravenous Thrombolysis in Patients With Hyperacute Ischemic Stroke

Kwon DH, Jang SH, Park H, Sohn SI, Hong JH

Background: Intravenous recombinant tissue plasminogen activator (IV rtPA) is the mainstay of treatment for acute ischemic stroke to recanalize thrombosed intracranial vessels within 4.5 hours. Emergency carotid artery stenting for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intravenous Thrombolysis Prior to Mechanical Thrombectomy in Acute Ischemic Stroke: Silver Bullet or Useless Bystander?

Di Maria F, Mazighi M, Kyheng M, Labreuche , Rodesch G, Consoli A, Coskun O, Gory B, Lapergue B, on behalf of the ETIS (Endovascular Treatment in Ischemic Stroke) Study Group

BACKGROUND AND PURPOSE: Recent single-center series and meta-analyses suggest that mechanical thrombectomy (MT) without prior intravenous thrombolysis (IVT) might be equally effective to bridging therapy. We analyzed, within the Endovascular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cell free DNA: A Novel Predictor of Neurological Outcome after Intravenous Thrombolysis and/or Mechanical Thrombectomy in Acute Ischemic Stroke Patients

Vajpeyee A, Wijatmiko , Vajpeyee M, Taywade O

PURPOSE: Several blood markers have been evaluated in stroke patients, but their role remains limited in clinical practice. This study was designed to evaluate the utility of cell free DNA...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Renal Subcapsular Hematoma after Intravenous Thrombolysis in a Patient with Acute Cerebral Infarction

La YK, Kim JH, Lee KY

A 74-year-old female with acute cerebral infarction was treated with intravenous recombinant tissue plasminogen activator. Subsequent percutaneous transfemoral angiography and mechanical thrombectomy were performed due to a right middle cerebral...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent advances in thrombolysis of acute ischemic stroke

Kwon JH, Rha JH

  • KMID: 2342162
  • J Korean Med Assoc.
  • 2013 May;56(5):402-409.
Among the many advances in acute ischemic stroke (AIS) management, thrombolysis with intravenous (IV) tissue plasminogen activator (tPA) within 3 hours after symptom onset has been the only approved pharmacological...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intravenous t-PA Thrombolysis in an Acute Ischemic Stroke Patient With Takayasu's Arteritis

Cho HJ, Hyun JW, Park KD, Oh JY

  • KMID: 2137917
  • J Korean Neurol Assoc.
  • 2011 May;29(2):116-119.
The usefulness of intravenous tissue plasminogen activator (IVT) in patients with acute ischemic stroke related to Takayasu's arteritis (TA) has not been documented; it is not recommended due to the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Thrombolytic Therapy of Pulmonary Thromboembolism in Probable Sporadic Creutzfeldt-Jakob Disease

Chang JY, Jung JH, Chang YH, Kim SY

  • KMID: 2191926
  • J Korean Neurol Assoc.
  • 2009 Nov;27(4):405-408.
The effect of intravenous recombinant tissue plasminogen activator for patients with Creutzfeldt-Jakob disease (CJD) has yet to be determined. A woman with rapidly progressive cognitive decline, cerebellar dysfunction, and extrapyramidal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Safety and Effect of Continuous Intravenous Urokinase Therapy in Acute Ischemic Stroke ( Open Clinical Trial )

Doh WB, Lee BC, Lee IH, Kim SM, Kwon KH

  • KMID: 2342771
  • J Korean Neurol Assoc.
  • 1999 Mar;17(2):189-194.
BACKGROUND: Early thrombolysis with intra-arterial urokinase(UK) or intravenous(IV) t-PA may be beneficial for patients with acute ischemic stroke, but this therapy is unavailable in some circumstances and cannot be applied...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr